These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 23940289)

  • 1. Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.
    Jochmanová I; Yang C; Zhuang Z; Pacak K
    J Natl Cancer Inst; 2013 Sep; 105(17):1270-83. PubMed ID: 23940289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors.
    Jochmanová I; Zelinka T; Widimský J; Pacak K
    Physiol Res; 2014; 63(Suppl 2):S251-62. PubMed ID: 24908231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.
    López-Jiménez E; Gómez-López G; Leandro-García LJ; Muñoz I; Schiavi F; Montero-Conde C; de Cubas AA; Ramires R; Landa I; Leskelä S; Maliszewska A; Inglada-Pérez L; de la Vega L; Rodríguez-Antona C; Letón R; Bernal C; de Campos JM; Diez-Tascón C; Fraga MF; Boullosa C; Pisano DG; Opocher G; Robledo M; Cascón A
    Mol Endocrinol; 2010 Dec; 24(12):2382-91. PubMed ID: 20980436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.
    Vicha A; Musil Z; Pacak K
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):186-91. PubMed ID: 23481210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
    Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
    Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Landscape of Pheochromocytoma and Paraganglioma.
    Jochmanova I; Pacak K
    Trends Cancer; 2018 Jan; 4(1):6-9. PubMed ID: 29413423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.
    Pang Y; Yang C; Schovanek J; Wang H; Bullova P; Caisova V; Gupta G; Wolf KI; Semenza GL; Zhuang Z; Pacak K
    Oncotarget; 2017 Apr; 8(14):22313-22324. PubMed ID: 28423608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome.
    Taïeb D; Yang C; Delenne B; Zhuang Z; Barlier A; Sebag F; Pacak K
    J Clin Endocrinol Metab; 2013 May; 98(5):E908-13. PubMed ID: 23539726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
    Shankavaram U; Fliedner SM; Elkahloun AG; Barb JJ; Munson PJ; Huynh TT; Matro JC; Turkova H; Linehan WM; Timmers HJ; Tischler AS; Powers JF; de Krijger R; Baysal BE; Takacova M; Pastorekova S; Gius D; Lehnert H; Camphausen K; Pacak K
    Neoplasia; 2013 Apr; 15(4):435-47. PubMed ID: 23555188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
    Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma.
    Peng S; Zhang J; Tan X; Huang Y; Xu J; Silk N; Zhang D; Liu Q; Jiang J
    Front Endocrinol (Lausanne); 2020; 11():586857. PubMed ID: 33329393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the natural antisense hypoxia-inducible factor-1alpha transcript is associated with malignant pheochromocytoma/paraganglioma.
    Span PN; Rao JU; Oude Ophuis SB; Lenders JW; Sweep FC; Wesseling P; Kusters B; van Nederveen FH; de Krijger RR; Hermus AR; Timmers HJ
    Endocr Relat Cancer; 2011 Jun; 18(3):323-31. PubMed ID: 21422080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new twist in neuroendocrine tumor research: Pacak-Zhuang syndrome, HIF-2α as the major player in its pathogenesis and future therapeutic options.
    Jochmanova I; Lazurova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):175-80. PubMed ID: 24781045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.
    Richter S; Qin N; Pacak K; Eisenhofer G
    Adv Pharmacol; 2013; 68():285-317. PubMed ID: 24054150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.
    Vicha A; Taieb D; Pacak K
    Endocr Relat Cancer; 2014 Jun; 21(3):R261-77. PubMed ID: 24500761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications.
    Imperiale A; Moussallieh FM; Roche P; Battini S; Cicek AE; Sebag F; Brunaud L; Barlier A; Elbayed K; Loundou A; Bachellier P; Goichot B; Stratakis CA; Pacak K; Namer IJ; Taïeb D
    Neoplasia; 2015 Jan; 17(1):55-65. PubMed ID: 25622899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytoma: The First Metabolic Endocrine Cancer.
    Jochmanova I; Pacak K
    Clin Cancer Res; 2016 Oct; 22(20):5001-5011. PubMed ID: 27742786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary Diseases Predisposing to Pheochromocytoma (VHL, NF-1, Paraganglioma Syndromes, and Novel Genes).
    Sarkadi B; Patócs A
    Exp Suppl; 2019; 111():129-147. PubMed ID: 31588531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.
    Wang Y; Liu B; Li F; Zhang Y; Gao X; Wang Y; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1274239. PubMed ID: 37867526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.